Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 4, 2012, Pages 588-601

  Allen, Patricia J ^a   D'Anci, Kristen E ^a,d   Kanarek, Robin B ^a   Renshaw, Perry F ^b,c  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Department of Veteran Affairs VISN 19 MIRECC ^*  (United States)

^d SALEM STATE UNIVERSITY   (United States)

Author keywords

Antidepressant; Creatine; Fluoxetine; Forced swim test; Major depressive disorder; Mood; Sex differences

Indexed keywords

ANTIDEPRESSANT AGENT; CREATINE; FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; DIETARY INTAKE; ESTRUS CYCLE; FEMALE; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; TREATMENT DURATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; CREATINE; DEPRESSION; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; ESTRUS; FEMALE; FLUOXETINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS;

ANIMALIA; RATTUS; RODENTIA;

EID: 84859055326     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.03.005     Document Type: Article

References (84)

1. F.R. Agostinho, G. Scaini, G.K. Ferreira, I.C. Jeremias, G.Z. Réus, and G.T. Rezin Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain Brain Res Bull 80 2009 337 340
2. H. Agren, and F. Niklasson Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note J Neural Transm 74 1988 55 59
3. P.J. Allen, K.E. D'Anci, R.B. Kanarek, and P.F. Renshaw Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner Neuropsychopharmacology 35 2010 534 546
4. L.S. Almeida, G.S. Salomons, F. Hogenboom, C. Jakobs, and A.N. Schoffelmeer Exocytotic release of creatine in rat brain Synapse 60 2006 118 123
5. D. Amital, T. Vishne, S. Roitman, M. Kotler, and J. Levine Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder J Clin Psychiatry 67 2006 836 837
6. D. Amital, T. Vishne, A. Rubinow, and J. Levine Observed effects of creatine monohydrate in a patient with depression and fibromyalgia Am J Psychiatry 163 2006 1840 1841
7. R. Andres, A. Ducray, U. Schlattner, T. Wallimann, and H. Widmer Functions and effects of creatine in the central nervous system Brain Res Bull 76 2008 329 343
8. R. Andres, A. Huber, U. Schlattner, A. Perezbouza, S. Krebs, and R. Seiler Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue Neuroscience 133 2005 701 713
9. S. Arnold, and C. Beyer Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target J Neurochem 110 2009 1 11
10. L.C. Assis, G.T. Rezin, C.M. Comim, S.S. Valvassori, I.C. Jeremias, and A.I. Zugno Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats Rev Bras Psiquiatr 31 2009 247 252
11. C. Behl Estrogen can protect neurons: modes of action J Steroid Biochem Mol Biol 83 2002 195 197
12. A. Blokland, S. ten Oever, D. van Gorp, M. van Draanen, T. Schmidt, E. Nguyen, A. Krugliak, A. Napoletano, S. Keuter, and I. Klinkenberg The use of a test battery assessing affective behavior in rats: order effects Behav Brain Res 228 2012 16 21
13. M. Búrigo, C.A. Roza, C. Bassani, G. Feier, F. Dal-Pizzol, and J. Quevedo Decreased creatine kinase activity caused by electroconvulsive shock Neurochem Res 31 2006 877 881
14. W.A. Carlezon Jr., S.D. Mague, and S.L. Andersen Enduring behavioral effects of early exposure to methylphenidate in rats Biol Psychiatry 54 2003 1330 1337
15. J.F. Cryan, M.E. Page, and I. Lucki Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment Psychopharmacology (Berl) 182 2005 335 344
16. J.F. Cryan, R.J. Valentino, and I. Lucki Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test Neurosci Biobehav Rev 29 2005 547 569
17. B. Czéh, T. Michaelis, T. Watanabe, J. Frahm, G. de Biurrun, and M. van Kampen Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine Proc Natl Acad Sci 98 2001 12796 12801
18. S.R. Dager, S.D. Friedman, A. Parow, C. Demopulos, A.L. Stoll, and I.K. Lyoo Brain metabolic alterations in medication-free patients with bipolar disorder Arch Gen Psychiatry 61 2004 450 458
19. C. Dalla, and T.J. Shors Sex differences in learning processes of classical and operant conditioning Physiol Behav 97 2009 229 238
20. P. Dechent, P.J. Pouwels, B. Wilken, F. Hanefeld, and J. Frahm Increase of total creatine in human brain after oral supplementation of creatine-monohydrate Am J Physiol 277 1999 R698 R704
21. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology (Berl) 121 1995 66 72
22. M.J. Detke, J. Johnson, and I. Lucki Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression Exp Clin Psychopharmacol 5 1997 107 112
23. W.C. Drevets, J.L. Price, and M.L. Furey Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression Brain Struct Funct 213 2008 93 118
24. V. Erakovic, G. Zupan, J. Varljen, J. Laginja, and A. Simonic Altered activities of rat brain metabolic enzymes in electroconvulsive shock-induced seizures Epilepsia 42 2001 181 189
25. R.J. Ferrante, O.A. Andreassen, B.G. Jenkins, A. Dedeoglu, S. Kuemmerle, and J.K. Kubilus Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease J Neurosci 20 2000 4389 4397
26. E. Fuchs, B. Czeh, T. Michaelis, G. de Biurrun, T. Watanabe, and J. Frahm Synaptic plasticity and tianeptine: structural regulation Eur Psychiatry 17 Suppl. 3 2002 311 317
27. V. Gabbay, D.A. Hess, S. Liu, J.S. Babb, R.G. Klein, and O. Gonen Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study Am J Psychiatry 164 2007 1881 1889
28. R.F. Gledhill, C.A. Van der Merwe, M. Greyling, and M.M. Van Niekerk Race-gender differences in serum creatine kinase activity: a study among South Africans J Neurol Neurosurg Psychiatry 51 1988 301 304
29. H. Hamakawa, T. Kato, T. Shioiri, T. Inubushi, and N. Kato Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder Psychol Med 29 1999 639 644
30. L.K. Heisler, R.B. Kanarek, and A. Gerstein Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats Pharmacol Biochem Behav 58 1997 767 773
31. L.K. Heisler, R.B. Kanarek, and B. Homoleski Reduction of fat and protein intakes but not carbohydrate intake following acute and chronic fluoxetine in female rats Pharmacol Biochem Behav 63 1999 377 385
32. H. Higuchi, K. Sato, S. Naito, K. Yoshida, H. Takahashi, and M. Kamata Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients Neuropsychiatr Dis Treat 5 2009 151 155
33. J. Hroudová, and Z. Fišar Connectivity between mitochondrial functions and psychiatric disorders Psychiatry Clin Neurosci 65 2011 130 141
34. Y. Hui, N. Huang, L. Ebbert, H. Bina, A. Chiang, and C. Maples Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs J Pharmacol Toxicol Methods 56 2007 256 264
35. D.V. Iosifescu, N.R. Bolo, A.A. Nierenberg, J.E. Jensen, M. Fava, and P.F. Renshaw Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder Biol Psychiatry 63 2008 1127 1134
36. O.S. Ipsiroglu, C. Stromberger, J. Ilas, H. Hoger, A. Muhl, and S. Stöckler-Ipsiroglu Changes of tissue creatine concentrations upon oral supplementation of creatine-monohydrate in various animal species Life Sci 69 2001 1805 1815
37. Y. Ji, B. Tang, and R.J. Traub The Visceromotor response to colorectal distention fluctuates with the estrous cycle in rats Neuroscience 154 2008 1562 1567
38. T. Kato, S. Takahashi, T. Shioiri, and T. Inubushi Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy J Affect Disord 26 1992 223 230
39. S.-Y. Kim, Y.-J. Lee, H. Kim, D.-W. Lee, D.-C. Woo, and C.-B. Choi Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo 1H-MRS study at 9.4 T Brain Res 1348 2010 105 113
40. Y. Koga, H. Takahashi, D. Oikawa, T. Tachibana, D. Denbow, and M. Furuse Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks Neuroscience 132 2005 65 71
41. D.G. Kondo, Y.-H. Sung, T.L. Hellem, K.K. Fiedler, X. Shi, and E.-K. Jeong Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study J Affect Disord 135 2011 354 361
42. D.G. Kondo, T.L. Hellem, Y.-H. Sung, N. Kim, E.-K. Jeong, and K.K. DelMastro Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder Depress Res Treat 2011 1 13
43. S.G. Kornstein, A.F. Schatzberg, M.E. Thase, K.A. Yonkers, J.P. McCullough, and G.I. Keitner Gender differences in chronic major and double depression J Affect Disord 60 2000 1 11
44. J. Lawler, W.S. Barnes, G. Wu, W. Song, and S. Demaree Direct antioxidant properties of creatine Biochem Biophys Res Commun 290 2002 47 52
45. B. Leuner, S. Mendolialoffredo, and T. Shors Males and females respond differently to controllability and antidepressant treatment Biol Psychiatry 56 2004 964 970
46. M.P. Leussis, and S.L. Andersen Is adolescence a sensitive period for depression? Behavioral and neuroanatomical findings from a social stress model Synapse 62 2008 22 30
47. W.J. Lynch Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats Pharmacol Biochem Behav 94 2009 43 50
48. I.K. Lyoo, and P.F. Renshaw Magnetic resonance spectroscopy: current and future applications in psychiatric research Biol Psychiatry 51 2002 195 207
49. I.K. Lyoo, S.W. Kong, S.M. Sung, F. Hirashima, A. Parow, and J. Hennen Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate Psychiatry Res 123 2003 87 100
50. V. Maletic, M. Robinson, T. Oakes, S. Iyengar, S.G. Ball, and J. Russell Neurobiology of depression: an integrated view of key findings Int J Clin Pract 61 2007 2030 2040
51. S.D. Malnick, A. Shaer, H. Soreq, and A.M. Kaye Estrogen-induced creatine kinase in the reproductive system of the immature female rat Endocrinology 113 1983 1907 1909
52. N. Michael, A. Erfurth, P. Ohrmann, V. Arolt, W. Heindel, and B. Pfleiderer Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression Psychol Med 33 2003 1277 1284
53. A. Michael-Titus, M. Albert, G. Michael, T. Michaelis, T. Watanabe, and J. Frahm SONU20176289, a compound combining partial dopamine D2 receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression Eur J Pharmacol 598 2008 43 50
54. Y. Mirza, J. O'Neill, E.A. Smith, A. Russell, J.M. Smith, and S.P. Banerjee Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls J Child Neurol 21 2006 106 111
55. C.M. Moore, J.D. Christensen, B. Lafer, M. Fava, and P.F. Renshaw Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study Am J Psychiatry 154 1997 116 118
56. A. Moretti, A. Gorini, and R.F. Villa Affective disorders, antidepressant drugs and brain metabolism Mol Psychiatry 8 2003 773 785
57. F.G. Nery, J.A. Stanley, H.-H. Chen, J.P. Hatch, M.A. Nicoletti, and E.S. Monkul Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel 1H spectroscopy study Psychiatry Res 174 2009 177 183
58. F. Niklasson, and H. Agren Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood Biol Psychiatry 19 1984 1183 1206
59. M. Oliveira, A. Furian, M. Fighera, N. Fiorenza, J. Ferreira, and M. Rubin The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement Behav Brain Res 187 2008 200 204
60. M.E. Page, M.J. Detke, A. Dalvi, L.G. Kirby, and I. Lucki Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test Psychopharmacology (Berl) 147 1999 162 167
61. L. Perasso, A. Cupello, G.L. Lunardi, C. Principato, C. Gandolfo, and M. Balestrino Kinetics of creatine in blood and brain after intraperitoneal injection in the rat Brain Res 974 2003 37 42
62. A.M. Persky, G.A. Brazeau, and G. Hochhaus Pharmacokinetics of the dietary supplement creatine Clin Pharmacokinet 42 2003 557 574
63. A.M. Persky, M. Müller, H. Derendorf, M. Grant, G.A. Brazeau, and G. Hochhaus Single- and multiple-dose pharmacokinetics of oral creatine J Clin Pharmacol 43 2003 29 37
64. L. Prut, and C. Belzung The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review Eur J Pharmacol 463 2003 3 33
65. O. Ramirez, and E. Jimenez Sexual dimorphism in rat cerebrum and cerebellum: different patterns of catalytically active creatine kinase isoenzymes during postnatal development and aging Int J Dev Neurosci 20 2002 627 639
66. P.F. Renshaw, A.M. Parow, F. Hirashima, Y. Ke, C.M. Moore, and B. Frederick Bde Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression Am J Psychiatry 158 2001 2048 2055
67. G.T. Rezin, G. Amboni, A.I. Zugno, J. Quevedo, and E.L. Streck Mitochondrial dysfunction and psychiatric disorders Neurochem Res 34 2008 1021 1029
68. S. Roitman, T. Green, Y. Osher, N. Karni, and J. Levine Creatine monohydrate in resistant depression: a preliminary study Bipolar Disord 9 2007 754 758
69. P.M. Santos, G. Scaini, G.T. Rezin, J. Benedet, N. Rochi, and G.C. Jeremias Brain creatine kinase activity is increased by chronic administration of paroxetine Brain Res Bull 80 2009 327 330
70. M. Segal, A. Avital, M. Drobot, A. Lukanin, A. Derevenski, and S. Sandbank Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients Eur Neuropsychopharmacol 17 2007 194 198
71. P. Sestili, C. Martinelli, G. Bravi, G. Piccoli, R. Curci, and M. Battistelli Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity Free Radic Biol Med 40 2006 837 849
72. P. Sestili, C. Martinelli, E. Colombo, E. Barbieri, L. Potenza, and S. Sartini Creatine as an antioxidant Amino Acids 40 2011 1385 1396
73. D. Sömjen, Y. Weisman, Z. Mor, A. Harell, and A.M. Kaye Regulation of proliferation of rat cartilage and bone by sex steroid hormones J Steroid Biochem Mol Biol 40 1991 717 723
74. I. Sora, K. Nishimon, and S. Otsuki Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders Biol Psychiatry 21 1986 621 631
75. R.D. Spence, and R.R. Voskuhl Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration Front Neuroendocrinol 33 2012 105 115
76. S. Stöckler, F. Hanefeld, and J. Frahm Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism Lancet 348 1996 789 790
77. M.G.C. van der Hart, B. Czéh, G. de Biurrun, T. Michaelis, T. Watanabe, and O. Natt Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume Mol Psychiatry 7 2002 933 941
78. T.N. Venkatraman, R.R. Krishnan, D.C. Steffens, A.W. Song, and W.D. Taylor Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression Psychiatry Res 172 2009 49 54
79. M. Vermeiden, W. van den Broek, P. Mulder, and T. Birkenhager Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients J Psychopharmacol (Oxf) 24 2009 497 502
80. H.P. Volz, R. Rzanny, S. Riehemann, S. May, H. Hegewald, and B. Preussler 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients Eur Arch Psychiatry Clin Neurosci 248 1998 289 295
81. A.A. Walf, and C.A. Frye Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model Gend Med 6 2009 300 311
82. T. Wallimann, M. Wyss, D. Brdiczka, K. Nicolay, and H.M. Eppenberger Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis Biochem J 281 Pt 1 1992 21 40
83. E.T. Wong, C. Cobb, M.K. Umehara, G.A. Wolff, L.J. Haywood, and T. Greenberg Heterogeneity of serum creatine kinase activity among racial and gender groups of the population Am J Clin Pathol 79 1983 582 586
84. E.A. Young, S.G. Kornstein, S.M. Marcus, A.T. Harvey, D. Warden, and S.R. Wisniewski Sex differences in response to citalopram: a STAR-D report J Psychiatr Res 43 2009 503 511